| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/01/2001 | US6225448 1gG /transferrin receptor fusion protein |
| 05/01/2001 | US6225446 Mutational variants of mammalian proteins |
| 05/01/2001 | US6225445 Fatty acid derivatives of sulfhydryl-containing compounds (for example, sulfhydryl-containing peptides or proteins) comprising fatty acid-conjugated products with a disulfide linkage |
| 05/01/2001 | US6225444 Bind calcium and which are useful in treating stroke and other neurodegenerative diseases |
| 05/01/2001 | US6225325 Administering n-substituted-1,5-dideoxy-1,5-imino-d-glucitol or galactitol for prophylaxis, therapy, reducing, or reversing multidrug resistance in patient undergoing therapy with chemotherapeutic agent |
| 05/01/2001 | US6225300 TNF receptor and steroid hormone in a combined therapy |
| 05/01/2001 | US6225292 Inhibitors of DNA immunostimulatory sequence activity |
| 05/01/2001 | US6225291 Rod opsin mRNA-specific ribozyme compositions and methods for the treatment of retinal diseases |
| 05/01/2001 | US6225290 Provides advantages:short term or long term cures and/or treatment, avoids invasive procedures, oral administration, naked dna is used rather than viral vectors, side-effects of long term gene administration can be avoided |
| 05/01/2001 | US6225288 Implicated in modulating apoptosis; treatment of:cardiac and cerebral ischemia/reperfusion injury, spinal cord injury and organ damage during transplantation, chronic neurodegenerative diseases, immunodeficiency, diabetes, alopecia, aging |
| 05/01/2001 | US6225287 Crystalline forms |
| 05/01/2001 | US6225286 Cell surface protein expressed on human cortical thymocyte and their use |
| 05/01/2001 | US6225285 Semaphorin K1 |
| 05/01/2001 | US6225284 Somatostatin peptides |
| 05/01/2001 | US6225283 Remedies for eating disturbance |
| 05/01/2001 | US6225282 Administration of trkb or trkc agonist neurotrophins; prevention or therapy of ototoxin-induced neuronal damage, loss, or degeneration of spiral ganglion neurons due to certain antibiotics, including aminoglycosides |
| 05/01/2001 | US6225120 Detection of modulator of receptor protein activity; providing nematode, isolated nematode cell or mammalian cell expressing receptor activity, incubate with modulator and detect amplification in receptor activity |
| 05/01/2001 | US6225115 DNA encoding taurine and GABA transporters and uses thereof |
| 05/01/2001 | US6225113 Genetically engineered vector for the transcription of heterologous genes in cells |
| 05/01/2001 | US6225102 Amino acid sequence of guanosine triphosphatase from streptococcus; diagnosis; prophylaxis; drug screening; bactericides; bacteriostats |
| 05/01/2001 | US6225098 UDP-N-acetylenolpyruvyglucosamine reductase |
| 05/01/2001 | US6225088 DNA encoding plasminogen-like growth factor (PLGF) and related embodiments |
| 05/01/2001 | US6225087 Polynucleotide which codes for a polypeptide of defined amino acid sequence; drug screening of bactericides against streptococcus; otitis media; conjunctivitis; pneumonia; meningitis; sinusitis; pleural empyema; endocarditis |
| 05/01/2001 | US6225085 Nucleotide and amino acid sequence of leucine-rich surface glycoprotein; diagnosis; prophylaxis; therapy; drug screening; fusion proteins; antigenic peptides; antibodies; recombinant production |
| 05/01/2001 | US6225084 Nucleotide and amion acid sequence of genes that are up-regulated in endothelial cells subjected to shear stress; atherosclerosis, antiischemic agents; hypotensive agents; restenosis; antiinflammatory agents for arteries |
| 05/01/2001 | US6225083 Nucleotide and amino acid sequences of membrane protein involved in cell division; drug screening; bactericides; bacteriostats; antibiotics; for meningitis, sinusitis, conjunctivitis, otitis media, and endocarditis |
| 05/01/2001 | US6225070 Antibodies to oxidation-specific epitopes on lipoprotein and methods for their use in detecting, monitoring and inhibiting the growth of atheroma |
| 05/01/2001 | US6225057 Duplications of human chromosome 15q24-25 and anxiety disorders, diagnostic methods for their detection |
| 05/01/2001 | US6225054 Compositions and methods for the treatment and diagnosis of breast cancer |
| 05/01/2001 | US6225045 Drug screening of viricides against human immunodeficiency virus; incubating rev protein with nucleic acid having nucleation and oligomerization motifs in presence of candidate, detecting decreased binding as indicator |
| 05/01/2001 | US6225042 Culturing genetically engineered, antigen presenting insect cell line so that major histocompatibility class i molecules bound to selected peptide are produced on surface of cell, then contacting with cd8 t cells |
| 05/01/2001 | US6224912 Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment |
| 05/01/2001 | US6224902 Mixture of delivery vehicle and sterol |
| 05/01/2001 | US6224901 Method for delivering beneficial compositions to hair follicles |
| 05/01/2001 | US6224889 Active composition for combating the effects of the cold and cosmetic product containing this composition |
| 05/01/2001 | US6224881 DNA molecule fragments encoding for cellular uptake of Mycobacterium tuberculosis and uses thereof |
| 05/01/2001 | US6224879 Genetic engineering |
| 05/01/2001 | US6224871 Dietary supplement for nutritionally promoting healthy joint function |
| 05/01/2001 | US6224869 Isolated polypeptide |
| 05/01/2001 | US6224865 Suppression of inhibitors |
| 05/01/2001 | US6224862 Mixture of prothrombinase and protein; anticoagulant |
| 05/01/2001 | US6224859 Composition containing immature mammalian dendritic cells for enhancing tolerogenicity to foreign graft |
| 05/01/2001 | US6224858 Hepatocytes transduced with a retroviral vector comprising splice sites and methods of expression |
| 05/01/2001 | CA2268703C Enantiomerically pure .beta.-d-dioxolane nucleosides with selective anti-hepatitis b virus activity |
| 05/01/2001 | CA2195395C Cyclic hexapeptide somatostatin analogues |
| 05/01/2001 | CA2150939C Stable protein: phospholipid compositions and methods |
| 05/01/2001 | CA2121473C Methods and compositions for treating allergic reactions |
| 05/01/2001 | CA2081660C Method for improving the organoleptic qualities of the meat from uncastrated male domestic animals and vaccine set for use in this method |
| 05/01/2001 | CA2046303C Il-1 biological activity inhibitors |
| 05/01/2001 | CA2001265C Analogs of peptidase substrates |
| 05/01/2001 | CA1341223C Dna clone of human tissue factor inhibitor |
| 05/01/2001 | CA1341222C Preparations of islet amyloid polypeptide (iapp) and antibodies to iapp |
| 05/01/2001 | CA1341220C Cloning and characterization of the bovine interleukin-2-gene |
| 05/01/2001 | CA1341219C Site specific mutagenesis in alpha-1-antitrypsin |
| 04/29/2001 | CA2322903A1 Treatment, diagnosis and evaluation of anti-cancer therapy resistance in melanoma |
| 04/29/2001 | CA2322687A1 Compositions containing c-terminal polypeptides of angiogenic chemokines and methods of use |
| 04/29/2001 | CA2286401A1 Methods of diagnosing and treating melanoma utilizing tyrp2 |
| 04/26/2001 | WO2001029564A1 Protein tyrosine kinase receptor polynucleotides, polypeptides, and antibodies |
| 04/26/2001 | WO2001029563A1 Method of screening for inhibitors of asp2 |
| 04/26/2001 | WO2001029235A2 Tms1 compositions and methods of use |
| 04/26/2001 | WO2001029234A2 Self-cleaving rna sequences and their use for the control of protein synthesis |
| 04/26/2001 | WO2001029233A2 Chimeric immunogenic compositions and nucleic acids encoding them |
| 04/26/2001 | WO2001029229A1 Novel polypeptide, human retinoblastoma binding protein 20 and polynucleotide encoding it |
| 04/26/2001 | WO2001029228A1 A novel polypeptide, a human casein kinase 48 and the polynucleotide encoding the polypeptide |
| 04/26/2001 | WO2001029225A1 A general method for optimizing the expression of heterologous proteins |
| 04/26/2001 | WO2001029221A2 Proteins and polynucleotides encoding them |
| 04/26/2001 | WO2001029220A2 Mage-a12 antigenic peptides and uses thereof |
| 04/26/2001 | WO2001029217A2 Novel polypeptides and polynucleotides encoding same |
| 04/26/2001 | WO2001029215A2 N-cam homolog and splice variants thereof |
| 04/26/2001 | WO2001029213A1 Human sit4 associated proteins like (sapl) proteins and encoding genes; uses thereof |
| 04/26/2001 | WO2001029201A1 Expression of recombinant mature lysostaphin |
| 04/26/2001 | WO2001029200A1 DNA ENCODING ENDO-β-GALACTOSIDASE |
| 04/26/2001 | WO2001029199A1 Methods for using 22045, a human cyclic nucleotide phosphodiesterase |
| 04/26/2001 | WO2001029193A2 Cell constructs that are suitable for immunotherapy, the production and the use thereof |
| 04/26/2001 | WO2001029178A2 Epo primary response gene 1, eprg1 |
| 04/26/2001 | WO2001029175A2 Antisense modulation of fra-1 expression |
| 04/26/2001 | WO2001029170A1 Protein-containing granules and granule formulations |
| 04/26/2001 | WO2001029129A1 Highly-neutralized ethylene copolymers and their use in golf balls |
| 04/26/2001 | WO2001029087A1 Transcription factor-selective nuclear transport receptors required for immune response activation |
| 04/26/2001 | WO2001029086A1 Peptides having corticotropin releasing factor (crf) antagonist activity |
| 04/26/2001 | WO2001029085A2 Cdt6 can inhibit angiogenesis and tumor growth, and can induce or enhance the formation of structures containing collagen v |
| 04/26/2001 | WO2001029084A2 Novel human proteins and polynucleotides encoding the same |
| 04/26/2001 | WO2001029082A1 A DNA MOLECULE ENCODING A VARIANT α2B-ADRENOCEPTOR PROTEIN, AND USES THEREOF |
| 04/26/2001 | WO2001029081A1 Modified peptides and peptidomimetics for use in immunotherapy |
| 04/26/2001 | WO2001029080A1 A novel polypeptide - human high mobility group protein 13 and a polynucleotide encoding the same |
| 04/26/2001 | WO2001029077A1 A novel polypeptide-human beta 2 microglobin regulatory factor 34 and the polynucleotide encoding said polypeptide |
| 04/26/2001 | WO2001029076A1 A novel polypeptide-human p24 protein-22 and the polynucleotide encoding said polypeptide |
| 04/26/2001 | WO2001029075A1 A novel polypeptide-g-protein activating protein 129 and the polynucleotide encoding the polypeptide |
| 04/26/2001 | WO2001029073A1 Methods for improving secondary metabolite production in fungi |
| 04/26/2001 | WO2001029071A2 Genes associated with obesity and methods for using the same |
| 04/26/2001 | WO2001029070A2 Modulation of t cell differentiation for the treatment of t helper cell mediated diseases |
| 04/26/2001 | WO2001029069A1 N-formyl peptide receptor complex with a g-protein kinase signal pathway modification agent |
| 04/26/2001 | WO2001029068A2 A eag gene encoding for a potassium channel |
| 04/26/2001 | WO2001029067A1 Tetrapeptide stimulating functional activity of neurones, pharmacological agent based thereon and method of use thereof |
| 04/26/2001 | WO2001029066A2 Basic monocyclic compounds having nk2 antagonist action, processes for their preparation, and formulations containing them |
| 04/26/2001 | WO2001029063A2 Death domain-containing receptor polynucleotides, polypeptides, and antibodies |
| 04/26/2001 | WO2001029058A1 Rna interference pathway genes as tools for targeted genetic interference |
| 04/26/2001 | WO2001029057A1 Antisense modulation of bcl-6 expression |
| 04/26/2001 | WO2001029056A1 Tadg-15: an extracellular serine protease overexpressed in carcinomas |
| 04/26/2001 | WO2001029054A2 Medicaments for treatment of respiratory syncytial virus infections |